Microscopic	0	11	O
technique	12	21	O
for	22	25	O
the	26	29	O
detection	30	39	O
of	40	42	O
nitric	43	49	B-Drug_or_compound
oxide	50	55	I-Drug_or_compound
-	55	56	O
dependent	56	65	O
angiogenesis	66	78	O
in	79	81	O
an	82	84	O
animal	85	91	O
model	92	97	O
.	97	98	O

Nitric	100	106	B-Drug_or_compound
oxide	107	112	I-Drug_or_compound
(	113	114	O
NO	114	116	B-Drug_or_compound
)	116	117	O
plays	118	123	O
an	124	126	O
important	127	136	O
role	137	141	O
in	142	144	O
maintaining	145	156	O
vascular	157	165	O
homeostasis	166	177	O
.	177	178	O

The	179	182	O
importance	183	193	O
of	194	196	O
NO	197	199	B-Drug_or_compound
in	200	202	O
the	203	206	O
vasculature	207	218	B-Anatomical_system
is	219	221	O
demonstrated	222	234	O
by	235	237	O
several	238	245	O
experimental	246	258	O
conditions	259	269	O
,	269	270	O
such	271	275	O
as	276	278	O
vascular	279	287	B-Gene_or_gene_product
endothelial	288	299	I-Gene_or_gene_product
growth	300	306	I-Gene_or_gene_product
factor	307	313	I-Gene_or_gene_product
(	314	315	O
VEGF	315	319	B-Gene_or_gene_product
)	319	320	O
-	320	321	O
induced	321	328	O
angiogenesis	329	341	O
.	341	342	O

Thus	343	347	O
,	347	348	O
the	349	352	O
NO	353	355	B-Drug_or_compound
metabolic	356	365	O
pathway	366	373	O
in	374	376	O
endothelial	377	388	B-Cell
cells	389	394	I-Cell
could	395	400	O
be	401	403	O
one	404	407	O
of	408	410	O
the	411	414	O
main	415	419	O
contributing	420	432	O
factors	433	440	O
for	441	444	O
angiogenesis	445	457	O
.	457	458	O

Although	459	467	O
several	468	475	O
methods	476	483	O
have	484	488	O
been	489	493	O
used	494	498	O
for	499	502	O
measuring	503	512	O
in	513	515	O
vitro	516	521	O
angiogenesis	522	534	O
,	534	535	O
a	536	537	O
proper	538	544	O
technique	545	554	O
has	555	558	O
not	559	562	O
been	563	567	O
developed	568	577	O
for	578	581	O
identifying	582	593	O
in	594	596	O
vivo	597	601	O
NO	602	604	B-Drug_or_compound
-	604	605	O
dependent	605	614	O
angiogenesis	615	627	O
.	627	628	O

This	629	633	O
chapter	634	641	O
provides	642	650	O
a	651	652	O
new	653	656	O
intravital	657	667	O
microscopic	668	679	O
method	680	686	O
for	687	690	O
detecting	691	700	O
and	701	704	O
measuring	705	714	O
NO	715	717	B-Drug_or_compound
-	717	718	O
dependent	718	727	O
angiogenesis	728	740	O
in	741	743	O
a	744	745	O
mouse	746	751	B-Organism
model	752	757	O
.	757	758	O

This	759	763	O
technique	764	773	O
showed	774	780	O
strong	781	787	O
abdominal	788	797	O
neovascularization	798	816	O
in	817	819	O
wild	820	824	O
-	824	825	O
type	825	829	O
mice	830	834	B-Organism
,	834	835	O
but	836	839	O
not	840	843	O
eNOS	844	848	B-Gene_or_gene_product
knockout	849	857	O
mice	858	862	O
,	862	863	O
locally	864	871	O
injected	872	880	O
with	881	885	O
VEGF	886	890	B-Gene_or_gene_product
,	890	891	O
as	892	894	O
well	895	899	O
as	900	902	O
stimulation	903	914	O
of	915	917	O
angiogenesis	918	930	O
in	931	933	O
NO	934	936	B-Drug_or_compound
donor	937	942	O
-	942	943	O
injected	943	951	O
mice	952	956	B-Organism
.	956	957	O

This	958	962	O
technique	963	972	O
also	973	977	O
revealed	978	986	O
the	987	990	O
inhibitory	991	1001	O
effect	1002	1008	O
of	1009	1011	O
the	1012	1015	O
NOS	1016	1019	B-Gene_or_gene_product
inhibitor	1020	1029	O
N	1030	1031	B-Drug_or_compound
(	1031	1032	I-Drug_or_compound
G	1032	1033	I-Drug_or_compound
)	1033	1034	I-Drug_or_compound
-	1034	1035	I-Drug_or_compound
iminoethyl	1035	1045	I-Drug_or_compound
-	1045	1046	I-Drug_or_compound
L	1046	1047	I-Drug_or_compound
-	1047	1048	I-Drug_or_compound
ornithine	1048	1057	I-Drug_or_compound
in	1058	1060	O
VEGF	1061	1065	B-Gene_or_gene_product
-	1065	1066	O
mediated	1066	1074	O
in	1075	1077	O
vivo	1078	1082	O
angiogenesis	1083	1095	O
.	1095	1096	O

This	1097	1101	O
chapter	1102	1109	O
describes	1110	1119	O
intravital	1120	1130	O
microscopy	1131	1141	O
as	1142	1144	O
a	1145	1146	O
new	1147	1150	O
imaging	1151	1158	O
technique	1159	1168	O
for	1169	1172	O
detecting	1173	1182	O
NO	1183	1185	B-Drug_or_compound
-	1185	1186	O
dependent	1186	1195	O
angiogenesis	1196	1208	O
in	1209	1211	O
an	1212	1214	O
animal	1215	1221	O
model	1222	1227	O
.	1227	1228	O

